Bone marrow transplantation for multiple sclerosis: Returning to Pandora's box

Richard K. Burt; William H. Burns; Stephen D. Miller

doi:10.1016/s0167-5699(97)01168-7

Bone marrow transplantation for multiple sclerosis: Returning to Pandora's box

Richard K. Burt^*, William H. Burns, Stephen D. Miller

^*Corresponding author for this work

Research output: Contribution to journal › Short survey › peer-review

28 Scopus citations

Abstract

As an immune-mediated demyelinating disease, could multiple sclerosis (MS) be treated by myeloablative therapy followed by bone marrow transplantation? Richard Burt and colleagues discuss preliminary data on this approach in the MS model of experimental allergic encephalomyelitis and in MS patients.

Original language	English (US)
Pages (from-to)	559-561
Number of pages	3
Journal	Immunology Today
Volume	18
Issue number	12
DOIs	https://doi.org/10.1016/s0167-5699(97)01168-7
State	Published - Dec 1997

ASJC Scopus subject areas

Immunology

Access to Document

10.1016/s0167-5699(97)01168-7

Cite this

@article{06fb0f1d699049caae229f9be9603fae,

title = "Bone marrow transplantation for multiple sclerosis: Returning to Pandora's box",

abstract = "As an immune-mediated demyelinating disease, could multiple sclerosis (MS) be treated by myeloablative therapy followed by bone marrow transplantation? Richard Burt and colleagues discuss preliminary data on this approach in the MS model of experimental allergic encephalomyelitis and in MS patients.",

author = "Burt, {Richard K.} and Burns, {William H.} and Miller, {Stephen D.}",

year = "1997",

month = dec,

doi = "10.1016/s0167-5699(97)01168-7",

language = "English (US)",

volume = "18",

pages = "559--561",

journal = "Trends in Immunology",

issn = "1471-4906",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Bone marrow transplantation for multiple sclerosis

T2 - Returning to Pandora's box

AU - Burt, Richard K.

AU - Burns, William H.

AU - Miller, Stephen D.

PY - 1997/12

Y1 - 1997/12

N2 - As an immune-mediated demyelinating disease, could multiple sclerosis (MS) be treated by myeloablative therapy followed by bone marrow transplantation? Richard Burt and colleagues discuss preliminary data on this approach in the MS model of experimental allergic encephalomyelitis and in MS patients.

AB - As an immune-mediated demyelinating disease, could multiple sclerosis (MS) be treated by myeloablative therapy followed by bone marrow transplantation? Richard Burt and colleagues discuss preliminary data on this approach in the MS model of experimental allergic encephalomyelitis and in MS patients.

UR - http://www.scopus.com/inward/record.url?scp=0031297333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031297333&partnerID=8YFLogxK

U2 - 10.1016/s0167-5699(97)01168-7

DO - 10.1016/s0167-5699(97)01168-7

M3 - Short survey

C2 - 9425730

AN - SCOPUS:0031297333

VL - 18

SP - 559

EP - 561

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 12

ER -

Bone marrow transplantation for multiple sclerosis: Returning to Pandora's box

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this